Načítá se...
Addressing COVID‐19 Drug Development with Artificial Intelligence
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus that led to the COVID‐19 (Coronavirus Disease 2019) pandemic, has resulted in substantial overburdening of healthcare systems as well as an economic crisis on a global scale. This has in turn resulted in widespr...
Uloženo v:
| Vydáno v: | Adv Intell Syst |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7235485/ https://ncbi.nlm.nih.gov/pubmed/32838299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/aisy.202000070 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|